new_logo_anew_logo_anew_logo_anew_logo_a
  • Company
    • Company
    • Our Mission
    • Leadership
    • Pipeline
  • Technology
    • Quantum Engine™
    • GTailor™
    • Quantum Nufect™
    • Quantum pBac™
    • iCellar™
    • qCART™
    • Protein / Target Hunter
  • Clinical trial
  • Partnership
  • Media
    • Events & Presentations
    • Publications
  • Careers
  • Contact Us
  • en_USEnglish
    • zh_TW繁體中文
✕
Our Founder/CEO/CSO, Sareina Wu will present our work as invited expert speakers and our COO/CSO, Karen Wen will present as invited moderator at the 2025 Antibody Therapeutic & The 20th Frontiers in Biomedical Sciences Conferencein Taipei, Taiwan. (May 26-27, 2025)
2025-03-11
GenomeFrontier Awarded $100,000 G-Rex® Grant to Advance Non-Viral CAR T Cell Therapy, GF-CART01
2025-05-05
GenomeFrontier Awarded $100,000 G-Rex® Grant to Advance Non-Viral CAR T Cell Therapy, GF-CART01
2025-05-05
Our Founder/CEO/CSO, Sareina Wu will present our work as invited expert speakers and our COO/CSO, Karen Wen will present as invited moderator at the 2025 Antibody Therapeutic & The 20th Frontiers in Biomedical Sciences Conferencein Taipei, Taiwan. (May 26-27, 2025)
2025-03-11

Our Founder/CEO/CSO, Sareina Wu and Director of Clinical development, Howard Cheng will present our work as invited expert speakers at the 10th Annual CAR-TCR Summit in Boston, US. (September 23-26, 2025)

More information: https://car-tcr-summit.com/

Share
0

留言 Cancel reply

Your email address will not be published. Required fields are marked *

Company

  • Our Mission
  • Leadership
  • Pipeline

Our Technology

  • GTailor
  • Quantum Nufect
  • Quantum pBac
  • iCellar
  • qCART
  • Protein / Target Hunter

Clinical Trial


Media

  • Events & Presentation
  • Publication

Partnership

Careers

Contact Us

© 2025 GenomeFrontier Therapeutics TW Co., Ltd. All Rights Reserved.